Hong Kong Exchanges and Clearing Limited

FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation

Form Serial Number:

DA20250926E00195
(Amendment to DA20250430E00520)

1. Date of relevant event:

30/04/2025
(dd/mm/yyyy)

2. Date when director became aware of the relevant event/ interest in the shares (if later):

(dd/mm/yyyy)

3. Stock code:

02096

4. Name of listed corporation:

Simcere Pharmaceutical Group Ltd.

5. Class of shares:

Ordinary Shares

6. Number of issued shares in class:

2,486,320,618

7. Name of director (English) as printed on HKID Card/Passport:

(Surname)	WANG
(Other names)	XI

10. Name of director (Chinese):

王熙

11. Chinese Character Code as printed on HKID Card:

24. Details of relevant event:

Brief description of relevant event

Capacity in which shares were/are held

Number of shares bought/sold or involved

Currency of transaction

On Exchange

Off Exchange

Before relevant event

After relevant event

Highest price (per share)

Average price (per share)

Average consideration (per share)

Consideration code

Long position

1213	The number of shares in which you are interested has reduced because: any other event (you must briefly describe the relevant event in the Supplementary Information box)

2305	Beneficiary of a trust (other than a discretionary interest)

16,400

Short position

25. Total shares in listed corporation immediately before the relevant event:

	Total number of shares	Percentage figure (%)
Long position	1,788,130,668	71.92

26. Total shares in listed corporation immediately after the relevant event:

	Total number of shares	Percentage figure (%)
Long position	1,788,114,268	71.92

27. Capacity in which interests disclosed in Box 26 are held:

Code describing capacity

Number of shares

2101	Beneficial owner

Long position

229,600

2305	Beneficiary of a trust (other than a discretionary interest)

Long position

56,000

2501	Other (you must describe the capacity in the Supplementary Information box)

Long position

1,787,828,668

28. Further information in derivative interests in listed corporation :

Derivatives code

Exercise period (dd/mm/yyyy)

Consideration - if derivatives granted by listed corporation

Number of shares

		Begins	Ends	Currency	Price for grant	Currency	Exercise price	Currency	Price on assignment

29. Further information in relation to interests of children under 18 and/or spouse:

Child/Spouse

Name of child/spouse

Number of shares

Spouse

Ren Jinsheng

Long position

1,787,828,668

30. Further information in relation to interests of corporations controlled by Director:

Name of controlled corporation	Address and place of incorporation	Name of controlling person	% control	Direct interest (Y/N)	Number of shares

31. Further information in relation to interests held by Director jointly with another person:

Name of joint shareholder	Address	Number of shares

32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:

Names of Trust	Address	Status code	Number of shares

33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):

Names of other parties	Address	Number of shares

Total number of shares in which a director is interested under sections 317 and 318

34. Supplementary information:

16,400 shares underlying restricted share units (RSUs) granted to Ms. Wang Xi were lapsed due to unsatisfication of vesting conditions and 65,600 shares underlying RSUs were vested on April 30, 2025. After that, Ms. Wang i)directly holds 229,600 shares; ii)is interested in 56,000 shares underlying RSUs (unvested) granted to her; and iii)is interested in 1,787,828,668 shares directly and indirectly held by her spouse (Ren Jinsheng) together with parties deemed to be persons acting in concert.

35. Log/Serial Number of the previous form:

DA20250430E00520

36. Number of concert party document(s) under section 317 attached/uploaded:

Date of filing this Form 3A:

26/09/2025
(dd/mm/yyyy)